The financials
Zai Lab Limited by the numbers
Zai Lab Limited (ZLAB) reported revenue of $100M in Q1 2026 (quarter ended Mar 31, 2026), down 6.5% from the same quarter a year earlier. That came with a gross margin of 62% and net loss of $51M. For the full year FY2025, revenue was $460M (+15% year on year) and net income −$176M. Its largest product in Jun 2026 was Zejula at $32M, 30% of the disclosed total, ahead of Vyvgart Vyvgart Hytrulo at 23%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $100M | $106M | −6.5% |
| Gross profit | $61M | $68M | −9.9% |
| Operating income | −$69M | −$56M | n/a |
| Net income | −$51M | −$48M | n/a |
| Diluted EPS | −$0.05 | −$0.04 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Zejula | $32M | 30% |
| Vyvgart Vyvgart Hytrulo | $24M | 23% |
| Nuzyra | $17M | 16% |
| Optune | $12M | 12% |
| Qinlock | $9.6M | 9.1% |
| XACDURO | $8.0M | 7.5% |
| AUGTYRO | $2.2M | 2.1% |
| Kar XT | $552K | 0.5% |
| Product And Service Other | $195K | 0.2% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $105.8M (+11%)
XACDURO grew +72% year on yearProduct And Service Other -43% year on year
Segment Latestquarter on quarteryear on year
- Zejula$32.1M$32.1MQoQ +7.0%year on year -22%+7.0%-22%
- Vyvgart Vyvgart Hytrulo$23.9M$23.9MQoQ +36%year on year -9.9%+36%-9.9%
- Nuzyra$17.1M$17.1MQoQ +5.1%year on year +20%+5.1%+20%
- Optune$12.2M$12.2MQoQ +1.1%year on year -1.2%+1.1%-1.2%
- Qinlock$9.6M$9.6MQoQ +6.7%year on year +12%+6.7%+12%
- XACDURO$8.0M$8.0MQoQ -7.2%year on year +72%-7.2%+72%
- AUGTYRO$2.2M$2.2MQoQ +23%year on year +58%+23%+58%
- Kar XT$552.0K$552.0KQoQ -year on year ---
- Product And Service Other$195.0K$195.0KQoQ -45%year on year -43%-45%-43%